Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
-6.97%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$10.4B
AUM Growth
-$1.51B
Cap. Flow
-$937M
Cap. Flow %
-8.99%
Top 10 Hldgs %
32.84%
Holding
1,227
New
66
Increased
465
Reduced
275
Closed
88

Sector Composition

1 Real Estate 74.79%
2 Technology 3.37%
3 Industrials 3.06%
4 Financials 2.76%
5 Healthcare 2.48%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GRFS icon
951
Grifois
GRFS
$6.72B
$15K ﹤0.01%
797
AGIO icon
952
Agios Pharmaceuticals
AGIO
$2.1B
$14K ﹤0.01%
314
FPI
953
Farmland Partners
FPI
$473M
$14K ﹤0.01%
3,000
ARNA
954
DELISTED
Arena Pharmaceuticals Inc
ARNA
$14K ﹤0.01%
367
+150
+69% +$5.72K
BPMC
955
DELISTED
Blueprint Medicines
BPMC
$13K ﹤0.01%
240
ELP icon
956
Copel
ELP
$6.75B
$13K ﹤0.01%
4,000
HALO icon
957
Halozyme
HALO
$8.9B
$12K ﹤0.01%
787
GHDX
958
DELISTED
Genomic Health, Inc.
GHDX
$12K ﹤0.01%
192
LAND
959
Gladstone Land Corp
LAND
$322M
$11K ﹤0.01%
1,000
MEDP icon
960
Medpace
MEDP
$13.6B
$11K ﹤0.01%
208
MYGN icon
961
Myriad Genetics
MYGN
$649M
$11K ﹤0.01%
383
RARE icon
962
Ultragenyx Pharmaceutical
RARE
$3.04B
$11K ﹤0.01%
260
MRTX
963
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$11K ﹤0.01%
+262
New +$11K
XLRN
964
DELISTED
Acceleron Pharma Inc.
XLRN
$11K ﹤0.01%
250
INVA icon
965
Innoviva
INVA
$1.27B
$10K ﹤0.01%
597
PCRX icon
966
Pacira BioSciences
PCRX
$1.18B
$10K ﹤0.01%
224
WVE icon
967
Wave Life Sciences
WVE
$1.19B
$10K ﹤0.01%
+237
New +$10K
GBT
968
DELISTED
Global Blood Therapeutics, Inc.
GBT
$10K ﹤0.01%
241
MYOK
969
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$10K ﹤0.01%
198
RUBY
970
DELISTED
Rubius Therapeutics, Inc
RUBY
$10K ﹤0.01%
+637
New +$10K
FOLD icon
971
Amicus Therapeutics
FOLD
$2.43B
$9K ﹤0.01%
919
OPK icon
972
Opko Health
OPK
$1.12B
$9K ﹤0.01%
3,091
SUPN icon
973
Supernus Pharmaceuticals
SUPN
$2.58B
$9K ﹤0.01%
283
XNCR icon
974
Xencor
XNCR
$593M
$9K ﹤0.01%
260
ANAB icon
975
AnaptysBio
ANAB
$619M
$8K ﹤0.01%
130